Part 1 - Introduction
1. Framing the issues
2. Matters of substance
Part 2 - Drug epidemiology and drug markets
3. The international dimensions of drug use
4. Harms associated with illicit drug use
5. Illegal markets: the economics of drug distribution and social
harm
6. The legal market: prescription and diversion of
psychopharmaceuticals
Part 3 - The Evidence base for drug policy: research on strategies
and interventions
7. Strategies and interventions to reduce drug use and related
harm: section overview
8. Preventing illicit drug use by young people
9. Health and social services for drug users
10. Supply control
11. Criminalization and decriminalization of drug use or
possession
12. Prescription regimes and other measures to control misuse of
psychopharmaceuticals
Part 4 - The policy arena
13. Drug Policy and Control at the International Level
14. The Variety of National Drug Policies
15. Health and social services for drug users: systems issues
Part 5 - Synthesis and conclusions
16. Summary and conclusions
Appendix A
Winner of 1st prize in the public health category of the British Medical Association Book Awards 2010
Thomas Babor is a Professor and Chairman in the Department of
Community Medicine and Health Care, University of Connecticut
School of Medicine. He holds the University's Physicians Health
Service endowed chair in Public Health and Community Medicine. Dr.
Babor received his doctoral degree in social psychology from the
University of Arizona in 1971. He spent several years in
postdoctoral research training in social psychiatry at Harvard
Medical School, and
subsequently served as head of social science research at McLean
Hospital's Alcohol and Drug Abuse Research Center in Belmont,
Massachusetts. Since 1997 he has been chairman of the Department of
Community
Medicine and Health Care at the University of Connecticut School of
Medicine. He is Associate Editor-in-Chief as well as Regional
Editor of the international journal, Addiction. His research
interests include screening, diagnosis, early intervention, and
treatment evaluation, as well as cultural and policy issues to
alcohol and drug problems. Jonathan P. Caulkins is Professor of
Operations Research and Public Policy at Carnegie Mellon
University's Qatar campus in Doha and its Heinz School of
Public Policy. He currently holds a Robert Wood Johnson Foundation
Health Investigator Award in Health Policy Research. Dr. Caulkins
specializes in mathematical modeling and systems analysis with
a
particular focus on social policy systems pertaining to drugs,
crime, terror, violence, and prevention. Other interests include
software quality, optimal control, airline operations, and
personnel performance evaluation. At RAND he has been a consultant,
visiting scientist, co-director of RAND's Drug Policy Research
Center (1994 - 1996), and founding director of RAND's Pittsburgh
office (1999-2001). Dr. Caulkins received a B.S., and M.S. in
Systems Science from Washington University, an S.M.
in Electrical Engineering and Computer Science and Ph.D., in
Operations Research both from M.I.T. Griffith Edwards qualified in
medicine and subsequently specialised in the study and treatment
of
substance misuse. Holder of Jellinek award (International Alcohol
Research prize) and Nathan Eddy Award (International Drugs Research
prize). Distinguished Fellow of the Society for the Study of
Addiction. Fellow of the Academy of Medical Sciences. David
Foxcroft is a Chartered Psychologist specializing in Prevention
Science. His major research interest is in the prevention of drug
and alcohol misuse, especially in young people. David graduated
from Hull University in 1990 with a BSc (Hons) in
Psychology, and in 1993 with a PhD in Health Psychology. He
subsequently held posts at the Universities of Portsmouth and
Southampton before coming to Oxford Brookes in 1999. Keith
Humphreys, Professor
of Psychiatry at Stanford University School of Medicine, received
his doctorate in clinical/community psychology from the University
of Illinois at Urbana, and his practice license from the State of
California Board of Psychology. He currently directs the Veterans
Affairs Program Evaluation and Resource Center, which studies
treatments and self-help programs for substance abuse and
psychiatric disorders. In addition to his scientific projects, he
is actively involved in teaching addiction
treatment methods to medical students, psychiatric residents, and
clinical psychology interns. Professor Humphreys has published more
than one hundred scientific articles, has received national and
international awards for his work, and has been a consultant to
science and human service agencies in the United States, Spain,
Bulgaria, Iraq, Ireland, Canada, and South Africa. Isidore Obot is
Professor of Psychology at the University of Uyo, Nigeria, and
Director, at the Centre for Research and Information on Substance
Abuse (CRISA). Before his appointment in Uyo in 2008, he was
Professor and Chair in the Department of Behavioral Health Sciences
at Morgan State University School of Public
Health, worked as a scientist in the Department of Mental Health
and Substance Abuse at the World Health Organization, Geneva, for
five years, and as a lecturer at the University of Jos, for
seventeen
years. Prof. Obot is a graduate of Howard University, Washington,
DC where he received his doctorate degree in psychology, and the
Harvard School of Public Health. He has also held post-doctoral
positions at the University of Michigan, Ann Arbor, and the Johns
Hopkins University School of Public Health. Jürgen Rehm has been
working in the area of substance use for over a decade and is
Co-Head of the "Public Health and Regulatory Policy " section at
the Centre for Addiction and Mental
Health in Toronto, Canada. He also holds a Chair position in
Addiction Policy, Dalla Lana School of Public Health, University of
Toronto, and is Director of the WHO Collaboration Centre on
Substance Abuse at
Zurich. Dr Rehm was awarded with the Jellinek Memorial Fund Award
for outstanding contributions to the advancement of knowledge on
alcohol/alcoholism: exemplary research contributions of fundamental
importance in alcohol epidemiology and for international leadership
in the applications of state-of-the-art methods in population
studies in 2003.
Peter Reuter is an economist who has been studying illegal markets
and drug policy for over twenty years. He is the founding president
of the International Society for the Study of Drug Policy and
author of four other scholarly books. Robin Room is an Australian
sociologist who worked for many years in alcohol and drug studies
in the U.S., Canada, Norway and Sweden. Since 2006, he has been a
Professor in the School of Population Health of the University of
Melbourne and the Director of the AER
Centre for Alcohol Policy Research at Turning Point Alcohol and
Drug Centre. He has worked on social, cultural and epidemiological
studies of alcohol, drugs and gambling behaviour and problems,
and
studies of social responses to alcohol and drug problems and of the
effects of policy changes. Ingeborg Rossow is research director at
the Norwegian Institute for Alcohol and Drug Research. Professor
John Strang is a leading Addictions clinician and academic, with 30
years' experience in various aspects of the diverse addictions
treatment field. He is Director of the National Addiction Centre
(NAC) covering both the academic work of the Addiction Research
Unit at the Institute of Psychiatry and
also the clinical services for people seeking help with drug or
alcohol problems across South London and more widely. In addiction
to his academic interest (with more than 300 addictions
publications), he has been a consultant psychiatrist in the
addictions for 26 years and has extensive experience as a lead
clinician in charge of a wide range of treatments in community and
residential settings. He has good working links with a range of
non-statutory residential treatment providers of care and
rehabilitation, including Clouds house (12-Step) and Phoenix
Futures (Therapeutic community).
It is a must read - and a very easy and enjoyable one - for any one
concerned with drug policy. All readers will find themselves armed
with essential relevant and contemporary context and evidence both
nationally and internationally.
*BMA Medical Book Competition*
Ask a Question About this Product More... |